EUROlinkCAT protocol for a European population-based data linkage study investigating the survival, morbidity and education of children with congenital anomalies.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 06 2021
Historique:
entrez: 29 6 2021
pubmed: 30 6 2021
medline: 4 8 2021
Statut: epublish

Résumé

Congenital anomalies (CAs) are a major cause of infant mortality, childhood morbidity and long-term disability. Over 130 000 children born in Europe every year will have a CA. This paper describes the EUROlinkCAT study, which is investigating the health and educational outcomes of children with CAs for the first 10 years of their lives. EUROCAT is a European network of population-based registries for the epidemiological surveillance of CAs. EUROlinkCAT is using the EUROCAT infrastructure to support 22 EUROCAT registries in 14 countries to link their data on births with CAs to mortality, hospital discharge, prescription and educational databases. Once linked, each registry transforms their case data into a common data model (CDM) format and they are then supplied with common STATA syntax scripts to analyse their data. The resulting aggregate tables and analysis results are submitted to a central results repository (CRR) and meta-analyses are performed to summarise the results across all registries. The CRR currently contains data on 155 594 children with a CA followed up to age 10 from a population of 6 million births from 1995 to 2014. The CA registries have the required ethics permissions for routine surveillance and transmission of anonymised data to the EUROCAT central database. Each registry is responsible for applying for and obtaining additional ethics and other permissions required for their participation in EUROlinkCAT. The CDM and associated documentation, including linkage and standardisation procedures, will be available post-EUROlinkCAT thus facilitating future local, national and European-level analyses to improve healthcare. Recommendations to improve the accuracy of routinely collected data will be made.Findings will provide evidence to inform parents, health professionals, public health authorities and national treatment guidelines to optimise diagnosis, prevention and treatment for these children with a view to reducing health inequalities in Europe.

Identifiants

pubmed: 34183346
pii: bmjopen-2020-047859
doi: 10.1136/bmjopen-2020-047859
pmc: PMC8240574
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e047859

Subventions

Organisme : Medical Research Council
ID : MR/K02325X/1
Pays : United Kingdom

Investigateurs

Abigail Reid (A)
Liz Limb (L)
Gillian Briggs (G)
Nicholas Connor (N)
Stine Kjaer Urhoj (SK)
Mads Damkjær (M)
Christina Neergaard Pedersen (CN)
Svetlana V Glinianaia (SV)
Gianni Astolfi (G)
Annarita Armaroli (A)
Elisa Ballardini (E)
Aurora Puccini (A)
Ljubica Boban (L)
Michele Santoro (M)
Alessio Coi (A)
Silvia Baldacci (S)
Lorena Mezzasalma (L)
L Renée Lutke (L)
Nicole H A Siemensma-Mühlenberg (NHA)
David Tucker (D)
Babak Khoshnood (B)
Nathalie Bertille (N)
Nathalie Lelong (N)
Makan Rahshenas (M)
Clara Cavero Carbonell (CC)
Óscar Zurriaga (Ó)
Laia Barrachina Bonet (LB)
Laura García Villodre (L)
Anna Jamry-Dziurla (A)
Anna Heino (A)
Sonja Kiuru-Kuhlefelt (S)
Mika Gissler (M)
Wladimir Wertelecki (W)
Lyubov Yevtushok (L)
Nataliia Zymak-Zakutnia (N)
Diana Akhmedzhanova (D)
Lyubov Ostapchuk (L)
Oksana Tsizh (O)
Serhii Lapchenko (S)
Carlos Matias Dias (CM)
Ausenda Machado (A)
Ana João Santos (AJ)
Liliana Antunes (L)
Paula Braz (P)
Hanitra Randrianaivo-Ranjatoelina (H)
Guy Thys (G)
Vera Nelen (V)
Elly Den Hond (ED)
Olatz Mokoroa Carollo (OM)
Daniel Thayer (D)
Ieuan Scanlon (I)
Sue Jordan (S)
Kari Klungsøyr (K)
Miriam Gatt (M)

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Birth Defects Res A Clin Mol Teratol. 2016 Nov;106(11):983-988
pubmed: 27891786
Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S44-50
pubmed: 21384529
Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):881-9
pubmed: 23616437
Eur J Med Genet. 2018 Sep;61(9):513-517
pubmed: 29597096
Arch Dis Child Fetal Neonatal Ed. 2015 Mar;100(2):F106-14
pubmed: 25359876
Indian J Pediatr. 2014 Oct;81(10):1005-9
pubmed: 24763813
Arch Dis Child. 2013 Dec;98(12):970-4
pubmed: 23968774
Arch Gynecol Obstet. 2019 Aug;300(2):337-345
pubmed: 31093740
Arch Dis Child. 2015 Dec;100(12):1148-54
pubmed: 26347387
Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):7-15
pubmed: 22753079
Lancet. 2014 Sep 13;384(9947):957-79
pubmed: 24797572
Birth Defects Res A Clin Mol Teratol. 2014 Nov;100(11):826-36
pubmed: 25124730
Br J Anaesth. 2018 Jun;120(6):1255-1273
pubmed: 29793593
Res Dev Disabil. 2011 Sep-Oct;32(5):1709-13
pubmed: 21458226
Arch Dis Child Fetal Neonatal Ed. 2018 Jan;103(1):F22-F28
pubmed: 28667189
Eur J Epidemiol. 2015 Nov;30(11):1153-64
pubmed: 25840712
Res Dev Disabil. 2013 Oct;34(10):3276-87
pubmed: 23892874
J Public Health Manag Pract. 2016 May-Jun;22(3):E9-E19
pubmed: 26125231
Lancet. 2010 Feb 20;375(9715):649-56
pubmed: 20092884
Birth Defects Res A Clin Mol Teratol. 2007 Nov;79(11):792-7
pubmed: 17990340
Acta Paediatr. 2018 May;107(5):845-853
pubmed: 29341296
Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S51-S100
pubmed: 21381185
J Matern Fetal Neonatal Med. 2012 Jan;25(1):68-73
pubmed: 21463211
Cochrane Database Syst Rev. 2018 Oct 15;10:CD012089
pubmed: 30321454
Birth Defects Res A Clin Mol Teratol. 2015 Sep;103(9):814-20
pubmed: 26069215
BMC Health Serv Res. 2012 Mar 09;12:58
pubmed: 22405490
J Public Health Manag Pract. 2010 May-Jun;16(3):245-51
pubmed: 20357611
Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S2-15
pubmed: 21384531
Ann R Coll Surg Engl. 2016 Jan;98(1):56-60
pubmed: 26688402
Am J Cardiol. 2017 May 15;119(10):1680-1686
pubmed: 28343600
Circulation. 2012 Aug 28;126(9):1143-72
pubmed: 22851541
Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S31-43
pubmed: 21381187
Eur J Hum Genet. 2013 Sep;21(9):1016-9
pubmed: 23321618
Am J Perinatol. 2019 Oct;36(12):1304-1309
pubmed: 30609432
J Surg Res. 2015 May 1;195(1):16-20
pubmed: 25703160
Lancet. 2018 May 19;391(10134):2008-2018
pubmed: 29731173

Auteurs

Joan K Morris (JK)

Population Health Research Institute, St George's University of London, London, UK jmorris@sgul.ac.uk.

Ester Garne (E)

Paediatric Department, Hospital Lillebaelt, Kolding, Denmark.

Maria Loane (M)

Faculty of Life and Health Sciences, Ulster University, Coleraine, UK.

Ingeborg Barisic (I)

Children's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.

James Densem (J)

Biomedical Computing Limited, Battle, UK.

Anna Latos-Bieleńska (A)

Polish Registry of Congenital Malformations, Chair and Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.

Amanda Neville (A)

IMER Registry (Emila Romagna Registry of Birth Defects), University Hospital of Ferrara, Emilia-Romagna, Italy.

Anna Pierini (A)

Instituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, Pisa, Italy.

Judith Rankin (J)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.

Anke Rissmann (A)

Malformation Monitoring Centre Saxony-Anhalt, Otto von Guericke University Medical Faculty, Magdeburg, Germany.

Hermien de Walle (H)

Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.

Joachim Tan (J)

Population Health Research Institute, St George's University of London, London, UK.

Joanne Emma Given (JE)

Faculty of Life and Health Sciences, Ulster University, Coleraine, UK.

Hugh Claridge (H)

Population Health Research Institute, St George's University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH